€1.64
0.00%
Xetra, Oct 06, 01:17 pm CEST. Market open.
ISIN
DE000A3H2101
Symbol
AAQ1
Index

Aap Implantate Stock price

€1.64
-0.11 6.29% 1M
+0.29 21.48% 6M
+0.22 15.49% YTD
-0.01 0.61% 1Y
+0.82 98.79% 3Y
-2.18 57.07% 5Y
-10.43 86.41% 10Y
-26.36 94.14% 20Y
Xetra, Closing price Mon, Oct 05 2026
-0.10 5.75%
ISIN
DE000A3H2101
Symbol
AAQ1
Index

Is Aap Implantate a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 9,121 stocks worldwide.

Key metrics

Basic
Market capitalization
€25.6m
Enterprise Value
€29.1m
Net debt
€3.5m
Cash
€520.0k
Shares outstanding
14.7m
Valuation
P/E
negative
P/S | estimate
2.1 | 1.3
EV/Sales | estimate
2.4 | 1.5
EV/FCF | ex SBC
negative | -
P/B
3.1
Financial Health
Equity Ratio
63.2%
Return on Equity
-29.7%
ROCE
-20.4%
ROIC
-20.0%
Debt/Equity
0.5
Financials
Revenue | estimate
€12.2m | €19.8m
EBITDA
€-480.0k
EBIT
€-2.6m
Net Income
€-2.7m
Free Cash Flow | ex SBC
€-2.3m | -
Growth
Revenue | estimate
-19.0% | 58.4%
EBITDA
-124.2%
EBIT
-1,808.0%
Net Income
-326.6%
Free Cash Flow
-155.7%
Margin
Gross
97.0%
EBITDA
-4.0%
EBIT
-21.0%
Net
-22.4%
Free Cash Flow | ex SBC
-18.4% | -
More
EPS
€-0.2
FCF per Share
€-0.2
Short interest
-
Employees
99
Rev per Employee
€130.0k

Aap Implantate Stock Analysis

Unlock Scores for Free

Analyst Opinions

9 Analysts have issued a Aap Implantate forecast:

3x Hold
33%
6x Sell
67%

Analyst Opinions

9 Analysts have issued a Aap Implantate forecast:

Hold
33%
Sell
67%

Financial data from Aap Implantate

Jun '26
+/-
%
12 12
19% 19%
100%
- Direct Costs 0.37 0.37
74% 74%
3%
12 12
12% 12%
97%
- Selling and Administrative Expenses 6.36 6.36
11% 11%
52%
- Research and Development Expense - -
-
-
-0.48 -0.48
124% 124%
-4%
- Depreciation and Amortization 2.08 2.08
14% 14%
17%
EBIT (Operating Income) EBIT -2.56 -2.56
1,808% 1,808%
-21%
Net Profit -2.73 -2.73
327% 327%
-22%

In millions EUR.

Don't miss a Thing! We will send you all news about Aap Implantate directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

aap Implantate AG is a medical device company, which engages in the development, manufacture, and market of trauma products for orthopedics. It offers trauma and biomaterials products which include anatomical plating system LOCTEQ, cannulated screws, standard plates and screws, bone cements, and mixing systems. The company was founded by Uwe Ahrens in 1990 and is headquartered in Berlin, Germany.

Head office Germany
CEO Mr. Girolamo
Employees 99
Founded 1990
Website www.aap.de

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today